Patents
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
06/2005
06/22/2005CN1629135A Method for separating L-phenylalanine from fermentation liquor
06/22/2005CN1207281C Trifluoromethyl-substd. spirocyclic ketoenols
06/22/2005CN1207275C Chiral compound (S)-(+)- and (R)-(-)-3-alkylamido-3-carboxy-1-phenyl propanone and prep. thereof
06/22/2005CN1207271C Aminoacid-iodine complex
06/22/2005CN1207270C Method for producing 5-aminosalicyclic acid
06/21/2005US6908935 Calcium receptor modulating agents
06/16/2005WO2005054276A1 Method for synthesis of perindopril and the pharmaceutically-acceptable salts thereof
06/16/2005WO2005054174A2 Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex
06/16/2005WO2005035482A3 Process for preparing aspartates
06/16/2005WO2005030701A3 Process for the preparation of lower toxicity quaternary ammonium compounds and compositions thereof
06/16/2005WO2005030135A3 Nitrosated glutamic acid compounds, compositions and methods of use
06/16/2005WO2005010011A3 Methods of synthesis of acyloxyalkyl compounds
06/16/2005US20050131250 neutralizing aqueous solution of chloroacetic acid with nonmetal amino or hydroxide base, reacting cis- or trans-1,2-diaminocyclohexane with neutralized chloroacetic acid at elevated temperature, treating product with non-metal amino or hydroxide base, treating resulting product with acid
06/16/2005US20050130936 N-protected epoxide intermediate for making various hydroxyethylamine Alzheimer's drugs such as N1-{(1S,2R)-1-benzyl-3-[(3,5-difluorobenzyl)amino]-2-hydroxypropyl}-N3, N3-dipropylisophthalamide
06/16/2005US20050130881 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
06/16/2005US20050130880 zinc(II) organic complex with ligands selected from aminoalkylpyridines, bis-optically active amino acids, bisaminoalkylcarboxylic acids, oligopeptides, oligopseudopeptides, di-substituted aminocarboxylic acids, alpha - and beta -hydroxycarboxylic acids, vitamins, glutamine; insulin mimetics; less toxic;
06/16/2005DE10352129A1 Verfahren zur Herstellung einer Organozinkverbindung und deren Verwendung in einer zinkhaltigen Zusammensetzung für die Nahrungsergänzung A process for the preparation of an organozinc compound and their use in a zinc-containing composition for the nutritional supplement
06/15/2005EP1541546A1 Crystal of amino acid ester salt and process for producing the same
06/15/2005EP1539729A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
06/15/2005EP1539697A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs
06/15/2005EP1539687A1 Substituted glycine derivatives for use as medicaments
06/15/2005EP1539139A2 Compositions and methods for separating amines and amino acids from their counter-enantiomers
06/15/2005EP1539134A2 Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
06/15/2005EP1173407B1 Method for nitrating aniline derivatives
06/15/2005EP1095009B1 A process for the preparation of 4-carboxy- 5,8,11- tris(carboxymethyl)- 1-phenyl- 2-oxa- 5,8,11- triazatridecan- 13-oic acid
06/15/2005EP1064252B1 Oxidation dyeing compositions containing a cationic coupling agent, novel cationic coupling agents
06/15/2005CN1627940A Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease
06/15/2005CN1626506A Preparing niclosamide in high purity and high yield
06/15/2005CN1626069A Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
06/15/2005CN1206207C Preparation method of cyanophthaofluoroaniline
06/15/2005CN1206205C Process for preparing R-salbutamol tartrate
06/15/2005CN1206204C Complex compound containing acidic functional group and method of preparing adipic acid/adipate using said complex compound
06/14/2005US6906215 Powdery s,s-ethylenediamine-n,n′-disuccinic acid iron complex and process for producing the same
06/14/2005US6906030 Carbon-substituted diketopiperazine delivery systems
06/14/2005US6905297 Locking nut, bolt and clip systems and assemblies
06/14/2005CA2359080C Method for reducing 3-dimethylamino-2-phenylpropion-acid ethyl ester-content in solutions of 2-dimethylamino-1-phenyl-3-cyclohexene-1-carboxylic acid ethyl ester
06/09/2005WO2005051890A1 Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40
06/09/2005WO2005051888A2 Diphenylamine derivatives
06/09/2005US20050124809 Process for producing quinazolin-4-one and derivatives thereof
06/09/2005US20050124668 Amino acids binding to proteins for treatment of pain, tumors, as antidepressants or cognition activators
06/09/2005US20050124655 Cyclization; solvent extraction; hydrolysis; phosphodiesterase (PDE IV) inhibitors
06/09/2005US20050124069 Transfection reagents
06/09/2005US20050123475 Preparation and use of alkylating agents
06/09/2005CA2547146A1 Diphenylamine derivatives
06/08/2005EP1538216A1 Process for producing optically active erythro 3-cyclohexylserines
06/08/2005EP1537080A1 Substituted spirocyclic ketoenols
06/08/2005EP1322594B1 Process for the preparation of alkyl n-alkylanthranilate
06/08/2005EP1278717A4 One-pot synthesis of alkyl 3-cyclopropylamino-2- 2,4-dibromo-3-(difluoromethoxy)benzoyl]-2-propenoate as a useful intermediate for antibacterial quinolone medicaments
06/08/2005EP1268398B1 Novel method for synthesis of n- (s)-1-carboxybutyl]-(s)-alanine esters and use in synthesis of perindopril
06/08/2005EP1252133B1 Pharmaceutical compounds
06/08/2005CN1625545A Method for preparing p-aminobenzoic acid
06/08/2005CN1205184C Beta-lactan
06/08/2005CN1205183C New amidino derivatives and their use as thrombin inhibitors
06/08/2005CN1205176C Stable salts of o-acetylsalicyclic with basic amino acids
06/07/2005US6903220 Synthesis of chiral 2-alkyl amino acids
06/07/2005US6903181 Subjecting the polysuccinimide to a ring-opening reaction with an amine, wherein said polysuccinimide is formed by polymerization of L-aspartic acid in a supercritical fluid
06/07/2005US6903128 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
06/02/2005WO2005049586A1 Process for production of (s) -n-pentanoyl-n-[[2’-(1h-tetrazole-5yl) [1,1’-biphenyl]-4-yl]methyl]-l-valine
06/02/2005WO2005028419A3 Asymmetric reductive amination of keto acid derivatives for producing amino acid derivatives
06/02/2005US20050119345 2-Amino-3-alkoxy-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives; effective for treating and preventing psychiatric disorders such as schizophrenia, anxiety, bipolar disorder and epilepsy, neurological diseases such as drug dependence, Alzheimer's disease, Huntington's chorea
06/02/2005US20050119256 Aromatic amino acid derivates and medicinal compositions
06/02/2005US20050119225 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs
06/02/2005US20050118706 Polymer arrays
06/02/2005US20050118248 fatty acid chain are derived from natural vegetable oils such as vernonia oil, lesquerella oil and castor oil, in which the several reactive groups such as epoxy, hydroxy and double bonds can be modified to polar and ionic groups
06/02/2005DE10349500A1 Verfahren zum Herstellen von 2-Dihalogenacyl-3-amino-acrylsäureestern und 3-Dihalogenmethyl-pyrazol-4-carbonsäureestern Acrylic acid esters, 2-dihaloacyl-3-amino-process for producing and 3-dihalomethyl-pyrazole-4-carboxylic acid esters
06/01/2005EP1534662A1 Process for recovering betaine
06/01/2005EP1169282B1 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor
06/01/2005EP1115695B1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
06/01/2005CN1622951A Powder trace element, method and device for making same
06/01/2005CN1204118C Comprehensive cystine mother liquor utilizing process of producing single amino acid and eliminating pollution
06/01/2005CN1203898C Perfluoroalkyl-containing metal complexes, its preparing method and use in NMR diagnostics
05/2005
05/31/2005US6900351 Formed via reacting ethylenediamine with malonic acid ester; for use as biodegradable chelating agents and sequestering agents; water treatment; pollution control
05/31/2005US6900244 Controlling lipid, cholesterol metabolism; anticholesterol agents
05/26/2005WO2005046878A2 Use of a derivative of aspartic acid as a collector in froth flotation processes
05/26/2005US20050113580 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption
05/26/2005US20050113570 Process for preparation of 7-[alpha-amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid
05/26/2005US20050113451 7-acetamidinyl derivatives
05/26/2005US20050113368 eg (+-) Ethyl 3-[4-{3-(3,4-dihydro-2H-benzo[b][1,4]oxazin-4-yl)propylamino}phenyl]-2-ethoxypropanoate; antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic
05/26/2005US20050113366 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
05/25/2005EP1533300A1 Organic amine salts of glutamic acid derivatives and their application
05/25/2005EP1533292A1 Dibenzylamine compound and medicinal use thereof
05/25/2005EP1532310A1 Method for delivering biologically active substances
05/25/2005DE10348022A1 Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
05/25/2005CN1203049C Rapid-dissolved ambroxol salt and preparing method thereof
05/24/2005US6897337 Labeling with methyl iodide
05/24/2005CA2174000C Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
05/24/2005CA2099162C Method and composition for inhibiting silica and silicate deposition
05/21/2005CA2486838A1 Organic amine salts of glutamic acid derivatives and their application
05/19/2005WO2005044780A1 Aminocarboxylic acid derivative, addition salt thereof, and s1p receptor control agent
05/19/2005WO2005044779A2 Process for the preparation of gabapentin
05/19/2005US20050107473 forming tert-leucine salts that is insoluble in solvents, then crystallizing and recovering the tert-leucine from the solvent, and a dissociating the salt
05/19/2005US20050107471 New esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
05/19/2005US20050107448 Calcium receptor antagonists
05/19/2005US20050107345 Aminoalkylphosphonates and related compounds as edg receptor agonists
05/19/2005US20050107321 FLK-1 is a receptor for vascular endothelial growth factor
05/19/2005US20050106689 Reacting an acetoacetate compound substituted on the C-4 atom by two or more halogen atoms, with ammonia or a primary or secondary amine in the presence of an "onium salt a reaction product of amine or ammonium with carboxylic acid
05/18/2005EP1301502B1 Compounds and their use as glycine transport inhibitors
05/18/2005EP1202952B1 Method for producing amines by homogeneously catalyzed reductive amination of carbonyl compounds
05/18/2005CN1617850A Dibenzylamine compound and medicinal use thereof
05/18/2005CN1617849A Hiv整合酶抑制剂 Hiv integrase inhibitors